NHL in Adolescents and Young Adults: A Unique Population

Authors

Jessica Hochberg, New York Medical CollegeFollow
Allyson Flower, New York Medical CollegeFollow
Laurence Brugieres
Mitchell S. Cairo, New York Medical CollegeFollow

DOI

10.1002/pbc.27073

Journal Title

Pediatric Blood & Cancer

First Page

e27073

Document Type

Article

Publication Date

5-1-2018

Department

Pediatrics

Abstract

Non-Hodgkin lymphoma (NHL) is a heterogeneous group of lymphoid malignancies with high incidence in adolescents and young adults (AYAs). The most common diseases include diffuse large B-cell lymphoma, anaplastic large cell lymphoma, Burkitt lymphoma, lymphoblastic lymphoma, and primary mediastinal large B-cell lymphoma. In comparison to younger children and adults, AYAs (15-39 years) with NHL present a specific set of challenges including variations in tumor biology, inconsistent treatment, pharmacodynamics, and psychosocial barriers. While survival of AYAs with NHL has improved, cure rates remain suboptimal. Incorporation of novel agents into pediatric-inspired treatment regimens specifically designed for NHL in AYAs has led to improved outcomes. Consideration of AYAs as a distinct population in the diagnosis and treatment of NHL is encouraged.

Recommended Citation

Hochberg, J., Flower, A., Brugieres, L., & Cairo, M. (2018). NHL in Adolescents and Young Adults: A Unique Population. Pediatric Blood & Cancer, 65 (8), e27073. https://doi.org/10.1002/pbc.27073